Masako Saitō

4.2k total citations · 1 hit paper
114 papers, 2.5k citations indexed

About

Masako Saitō is a scholar working on Atomic and Molecular Physics, and Optics, Molecular Biology and Immunology. According to data from OpenAlex, Masako Saitō has authored 114 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Atomic and Molecular Physics, and Optics, 15 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Masako Saitō's work include Dyeing and Modifying Textile Fibers (12 papers), Physics of Superconductivity and Magnetism (10 papers) and Color Science and Applications (9 papers). Masako Saitō is often cited by papers focused on Dyeing and Modifying Textile Fibers (12 papers), Physics of Superconductivity and Magnetism (10 papers) and Color Science and Applications (9 papers). Masako Saitō collaborates with scholars based in Japan, United States and Serbia. Masako Saitō's co-authors include Yoshiyuki Minegishi, Hidetoshi Fukuyama, Yasusei Kudo, Naozumi Ishimaru, Rieko Arakaki, Akiko Yamada, Hajime Karasuyama, Nobuaki Kawamura, Ikuya Tsuge and Tadashi Ariga and has published in prestigious journals such as Nature, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Masako Saitō

107 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

2007 704 citations Yoshiyuki Minegishi, Masako Saitō et al. Nature profile →

Peers

Countries citing papers authored by Masako Saitō

Since Specialization

Citations

This map shows the geographic impact of Masako Saitō's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Saitō with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Saitō more than expected).

Fields of papers citing papers by Masako Saitō

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Saitō. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Saitō. The network helps show where Masako Saitō may publish in the future.

Co-authorship network of co-authors of Masako Saitō

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Saitō. A scholar is included among the top collaborators of Masako Saitō based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Saitō. Masako Saitō is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population Pharmacokinetic Modeling and Simulation of Pudexacianinium (ASP5354) for Dose Setting of a Phase 2 First‐in‐Patient Study: A Novel Imaging Agent for Intraoperative Ureter Visualization during Abdominopelvic Surgery 2023 ·Clinical Pharmacology in Drug Development ·Masako Saitō, (unknown), Kanji Komatsu, (unknown)	3
2	Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects 2020 ·Clinical Drug Investigation ·Mai Shibata, (unknown), Masako Saitō, Junko Toyoshima, Yuichiro Kaneko, (unknown), Tetsuya Nishimura	4
3	Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus 2020 ·Diabetes Therapy ·Masako Saitō, Atsunori Kaibara, Takeshi Kadokura, Junko Toyoshima, Satoshi Yoshida, Kenichi Kazuta, Eiji Ueyama	0
4	ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial 2020 ·Arthritis Research & Therapy ·Tsutomu Takeuchi, Yoshiya Tanaka, (unknown), Yuichiro Kaneko, Masako Saitō, (unknown), Ronald Smulders, Christopher Lademacher	11
5	Achaete-Scute Homologue 2–Regulated Follicular Helper T Cells Promote Autoimmunity in a Murine Model for Sjögren Syndrome 2019 ·American Journal Of Pathology ·Kunihiro Otsuka, Akiko Yamada, Masako Saitō, (unknown), (unknown), (unknown), (unknown), Takaaki Tsunematsu, Yasusei Kudo, Rieko Arakaki, Naozumi Ishimaru	11
6	Long-term polarization of alveolar macrophages to a profibrotic phenotype after inhalation exposure to multi-wall carbon nanotubes 2018 ·PLoS ONE ·Kunihiro Otsuka, Koichi Yamada, (unknown), Rieko Arakaki, (unknown), Masako Saitō, Akiko Yamada, Takaaki Tsunematsu, Yasusei Kudo, Jun Kanno, Naozumi Ishimaru	14
7	Genome-first approach diagnosed Cabezas syndrome via novel CUL4B mutation detection 2017 ·Human Genome Variation ·Nobuhiko Okamoto, Miki Watanabe, Takuya Naruto, K. Matsuda, Tomohiro Kohmoto, Masako Saitō, Kiyoshi Masuda, Issei Imoto	11
8	A case with concurrent duplication, triplication, and uniparental isodisomy at 1q42.12-qter supporting microhomology-mediated break-induced replication model for replicative rearrangements 2017 ·Molecular Cytogenetics ·Tomohiro Kohmoto, (unknown), Takuya Naruto, Chie Murata, Yuya Ouchi, Naoko Fujita, Hidehito Inagaki, (unknown), Nobuhiko Okamoto, Masako Saitō, Kiyoshi Masuda, Hiroki Kurahashi, Issei Imoto	5
9	Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease 2016 ·Laboratory Investigation ·(unknown), Takaaki Tsunematsu, Akiko Yamada, Rieko Arakaki, Masako Saitō, Kunihiro Otsuka, (unknown), (unknown), Mie Kurosawa, Yasusei Kudo, Naozumi Ishimaru	4
10	Amplitude-integrated EEG revealed nonconvulsive status epilepticus in children with non-accidental head injury 2014 ·European Journal of Paediatric Neurology ·(unknown), Akihisa Okumura, (unknown), (unknown), Shinpei Abe, Mitsuru Ikeno, Masako Saitō, Tomoyuki Nakazawa, Toshiaki Shimizu	4
11	Physical complications in elderly patients with advanced dementia 2013 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·(unknown), (unknown), (unknown), Masako Saitō, Hiroko Takano, (unknown), Tatsuya Suzuki, Hiroshi Nakano	1
12	Amplitude spectral analyses of disorganized patterns on electroencephalograms in preterm infants 2012 ·Brain and Development ·Masako Saitō, Akihisa Okumura, Hiroyuki Kidokoro, Tetsuo Kubota, Shinpei Abe, Mitsuru Ikeno, Fumio Hayakawa, Toshiaki Shimizu, Kazuyoshi Watanabe	1
13	Effect of food on the pharmacokinetics of darexaban, an oral direct factor Xa inhibitor, in healthy Japanese subjects 2012 ·International Journal of Clinical Pharmacology and Therapeutics ·Takeshi Kadokura, Yuta Taniuchi, Hiroshi Inoue, Masako Saitō, (unknown), Shunsuke Yamada, Akinori Urae, Mashio Nakamura	3
14	Cutaneous Manifestations of Hyper IgE Syndrome 2012 ·Allergology International ·Yoshiyuki Minegishi, Masako Saitō	31
15	Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome breakdown → 2007 ·Nature ·Yoshiyuki Minegishi, Masako Saitō, Shigeru Tsuchiya, Ikuya Tsuge, Hidetoshi Takada, Toshiro Hara, Nobuaki Kawamura, Tadashi Ariga, Srdjan Pašić, Oliver Stojković, Ayşe Metìn, Hajime Karasuyama	704
16	Comparative study using rabbit‐derived polyclonal, mouse‐derived monoclonal, and rabbit‐derived monoclonal antibodies for KIT immunostaining in GIST and other tumors 2007 ·Pathology International ·Masako Saitō, Shinji Sakurai, Atsushi Motegi, Kana Saito, Takaaki Sano, Takashi Nakajima	7
17	Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: In vivo evidence of involvement of P-glycoprotein in risperidone disposition 2005 ·Clinical Pharmacology & Therapeutics ·Taku Nakagami, Norio Yasui‐Furukori, Masako Saitō, (unknown), (unknown)	59
18	Photochromism of Diarylethenes in DNA-Quaternary Ammonium Ion Complex 2003 ·KOBUNSHI RONBUNSHU ·Masako Saitō, (unknown), (unknown), Shin Ozawa, Yayoi Yokoyama, Yasushi Yokoyama	5
19	Ethyl hydroperoxide-dependent metabolism ofN,N-dimethyl-p-anisidine catalysed by lactoperoxidase 1990 ·Xenobiotica ·Hiroteru Sayo, Masako Saitō	1
20	Photo-Deterioration of Silk and Cotton 1987 ·Journal of home economics ·(unknown), Masako Saitō, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact